MyMD Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity (Details Narrative)

Equity (Details Narrative)									3 Months Ended				9 Months Ended
Equity (Details Narrative)	Aug. 17, 2022 USD ($) $ / shares shares	Jul. 07, 2022 USD ($) d $ / shares shares	Feb. 16, 2022 shares	Dec. 09, 2021 USD ($) $ / shares shares	Aug. 05, 2021 USD ($) shares	May 18, 2021 shares	Feb. 11, 2021 shares	Mar. 24, 2020 $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2021 shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 $ / shares shares	Apr. 16, 2021 shares	Apr. 15, 2021 shares
Class of Stock [Line Items]
Preferred stock, shares authorized									50,000,000				50,000,000		50,000,000
Preferred stock, no par value \| $ / shares									$ 0				$ 0		$ 0
Common stock, shares authorized									500,000,000				500,000,000		500,000,000
Issuance of common stock for warrants, shares	1,411,764
Fair market value of shares issued for services \| $											$ 90,002
Common stock options, exercised				11,576
Common stock options, exercise price \| $ / shares				$ 2.59					$ 2.64				$ 2.64		$ 2.59
Common stock options, proceeds \| $				$ 29,982
Issuance of warrant	1,411,764
Share price \| $ / shares	$ 4.25
Class of warrant or right, exercise price of warrants or rights \| $ / shares	$ 5.25	$ 5.98
Proceeds from Issuance of Common Stock \| $	$ 5,999,997												$ 5,550,028
Net proceeds from issuance of common stock \| $	$ 5,550,028
Fair value of warrants \| $		$ 93,233
Stock price per share \| $ / shares		$ 2.99
Stock Based Compensation \| $									$ 352,417				$ 581,663	$ 15,036,051
IPO [Member]
Class of Stock [Line Items]
Class of warrant or right, exercise price of warrants or rights \| $ / shares	$ 5.25
Maximum [Member] \| IPO [Member]
Class of Stock [Line Items]
Issuance of warrant	1,411,764
Measurement Input, Option Volatility [Member]
Class of Stock [Line Items]
Stock price per share \| d		131.06
Measurement Input, Discount Rate [Member]
Class of Stock [Line Items]
Stock price per share \| d		3.07
Merger Agreement [Member]
Class of Stock [Line Items]
Common stock, shares authorized																500,000,000	100,000,000
Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Issuance of common stock for warrants, shares							466,216
Common Stock [Member]
Class of Stock [Line Items]
Underlying shares of common stock									36,496				36,496
Issuance of common stock for warrants, shares									1,411,764
Number of shares, exchange			385,135			466,716
Shares issued for services					16,826						16,826
Fair market value of shares issued for services \| $					$ 90,002
Common stock options, exercised										385,135		466,716
Pre-funded Warrants [Member]
Class of Stock [Line Items]
Number of shares, exercised			385,135			466,216
Pre-funded Warrants [Member] \| Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Warrants, issued							466,216
Common Stock Warrants [Member]
Class of Stock [Line Items]
Number of shares, exercised
Class of warrant or right, exercise price of warrants or rights \| $ / shares									$ 2.61				$ 2.61		6.06
Warrant [Member]
Class of Stock [Line Items]
Issuance of common stock for warrants, shares		38,265
Class of warrant or right, exercise price of warrants or rights \| $ / shares		$ 5.98
Warrants term		5 years
Stock Based Compensation \| $									$ 78,210				$ 78,210
Pre Funded Common Stock Warrants [Member]
Class of Stock [Line Items]
Number of shares, exercised													385,135
Share price \| $ / shares									$ 6.06				$ 6.06		2.61
Series C Convertible Preferred Stock Warrants [Member]
Class of Stock [Line Items]
Number of shares, exercised
Share price \| $ / shares									$ 2.61				$ 2.61		$ 6.06
Series D Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized								211,353	211,353				211,353		211,353
Preferred stock, no par value \| $ / shares								$ 0	$ 0				$ 0		$ 0
Preferred stock value, per share \| $ / shares								0.01
Preferred stock value, per share \| $ / shares								0.01	$ 0.01				$ 0.01		$ 0.01
Preferred stock, conversion price \| $ / shares								$ 0.01
Preferred stock, terms of conversion								A holder of Preferred Stock will be prohibited from converting Preferred Stock into shares of the Company’s common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company’s common stock then issued and outstanding (with such ownership restriction referred to as the “Beneficial Ownership Limitation”). However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after such notice to the Company
Preferred stock, shares outstanding									72,992				72,992		72,992